Cargando…
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls
BACKGROUND: Intraoperative Cerenkov luminescence imaging (CLI) is a novel technique to assess surgical margins in patients undergoing nerve sparing radical prostatectomy (RP). Here, we analyze the efficacy of a 550-nm optical short-pass filter (OF) to improve its performance. METHODS: In this prospe...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575587/ https://www.ncbi.nlm.nih.gov/pubmed/34804840 http://dx.doi.org/10.21037/tau-20-1141 |
_version_ | 1784595704607408128 |
---|---|
author | Darr, Christopher Fragoso Costa, Pedro Kesch, Claudia Krafft, Ulrich Püllen, Lukas Harke, Nina Natascha Hess, Jochen Szarvas, Tibor Haubold, Johannes Reis, Henning Fendler, Wolfgang Peter Herrmann, Ken Radtke, Jan Philipp Hadaschik, Boris Alexander Tschirdewahn, Stephan |
author_facet | Darr, Christopher Fragoso Costa, Pedro Kesch, Claudia Krafft, Ulrich Püllen, Lukas Harke, Nina Natascha Hess, Jochen Szarvas, Tibor Haubold, Johannes Reis, Henning Fendler, Wolfgang Peter Herrmann, Ken Radtke, Jan Philipp Hadaschik, Boris Alexander Tschirdewahn, Stephan |
author_sort | Darr, Christopher |
collection | PubMed |
description | BACKGROUND: Intraoperative Cerenkov luminescence imaging (CLI) is a novel technique to assess surgical margins in patients undergoing nerve sparing radical prostatectomy (RP). Here, we analyze the efficacy of a 550-nm optical short-pass filter (OF) to improve its performance. METHODS: In this prospective single-center feasibility study ten patients with prostate cancer (PC) were included between December 2019 and April 2020, including three patients without tracer injection as a control group. After preoperative injection of 68-Ga-prostate-specific membrane antigen (PSMA)-11 followed by RP, CLI of the excised prostate and the incised index lesion was performed to visualize the primary tumor lesion. We compared the findings on intraoperative CLI to postoperative histopathology. Furthermore, CLI-intensities determined as tumor to background ratio (TBR) and contrast to noise ratio (CNR) were measured. RESULTS: Histopathology proved positive surgical margins (PSM) in 3 patients with corresponding findings in CLI. After magnetic resonance imaging (MRI)-informed incision above the index lesion 2 out of 3 prostates demonstrated elevated CLI signals with histopathological confirmation of PC cells. The use of the OF enabled a significant reduction of the area of the regions of interest from a median of 1.80 to 0.15 cm(2) (reduction by 85%, P=0.005) leading to increased specificity. Signals due to PSMs were not suppressed by the 550-nm OF. The median TBR was reduced from 3.33 to 2.10. In all three patients of the control group elevated CLI intensities were detected at locations with diathermal energy deposition during surgery. After application of the 550-nm OF these were almost totally suppressed with a TBR of 1.10. Measurements of Cerenkov luminescence intensity with the 550-nm OF showed a significant Pearson’s correlation of 0.82 between PSM and the elevated TBR (P=0.003) and a significant Pearson’s correlation of 0.66 between PSM and elevated CNR (P=0.04). Measurements without the OF did not correlate significantly. CONCLUSIONS: Intraoperative 68-Ga-PSMA CLI in PC is a tool that warrants further investigation to visualize PSM especially in intermediate and high-risk PC. Intraoperative CLI benefits from usage of a 550-nm OF to reduce false-positive signals. |
format | Online Article Text |
id | pubmed-8575587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-85755872021-11-18 Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls Darr, Christopher Fragoso Costa, Pedro Kesch, Claudia Krafft, Ulrich Püllen, Lukas Harke, Nina Natascha Hess, Jochen Szarvas, Tibor Haubold, Johannes Reis, Henning Fendler, Wolfgang Peter Herrmann, Ken Radtke, Jan Philipp Hadaschik, Boris Alexander Tschirdewahn, Stephan Transl Androl Urol Original Article on Management of Advanced Genitourinary Malignancies BACKGROUND: Intraoperative Cerenkov luminescence imaging (CLI) is a novel technique to assess surgical margins in patients undergoing nerve sparing radical prostatectomy (RP). Here, we analyze the efficacy of a 550-nm optical short-pass filter (OF) to improve its performance. METHODS: In this prospective single-center feasibility study ten patients with prostate cancer (PC) were included between December 2019 and April 2020, including three patients without tracer injection as a control group. After preoperative injection of 68-Ga-prostate-specific membrane antigen (PSMA)-11 followed by RP, CLI of the excised prostate and the incised index lesion was performed to visualize the primary tumor lesion. We compared the findings on intraoperative CLI to postoperative histopathology. Furthermore, CLI-intensities determined as tumor to background ratio (TBR) and contrast to noise ratio (CNR) were measured. RESULTS: Histopathology proved positive surgical margins (PSM) in 3 patients with corresponding findings in CLI. After magnetic resonance imaging (MRI)-informed incision above the index lesion 2 out of 3 prostates demonstrated elevated CLI signals with histopathological confirmation of PC cells. The use of the OF enabled a significant reduction of the area of the regions of interest from a median of 1.80 to 0.15 cm(2) (reduction by 85%, P=0.005) leading to increased specificity. Signals due to PSMs were not suppressed by the 550-nm OF. The median TBR was reduced from 3.33 to 2.10. In all three patients of the control group elevated CLI intensities were detected at locations with diathermal energy deposition during surgery. After application of the 550-nm OF these were almost totally suppressed with a TBR of 1.10. Measurements of Cerenkov luminescence intensity with the 550-nm OF showed a significant Pearson’s correlation of 0.82 between PSM and the elevated TBR (P=0.003) and a significant Pearson’s correlation of 0.66 between PSM and elevated CNR (P=0.04). Measurements without the OF did not correlate significantly. CONCLUSIONS: Intraoperative 68-Ga-PSMA CLI in PC is a tool that warrants further investigation to visualize PSM especially in intermediate and high-risk PC. Intraoperative CLI benefits from usage of a 550-nm OF to reduce false-positive signals. AME Publishing Company 2021-10 /pmc/articles/PMC8575587/ /pubmed/34804840 http://dx.doi.org/10.21037/tau-20-1141 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article on Management of Advanced Genitourinary Malignancies Darr, Christopher Fragoso Costa, Pedro Kesch, Claudia Krafft, Ulrich Püllen, Lukas Harke, Nina Natascha Hess, Jochen Szarvas, Tibor Haubold, Johannes Reis, Henning Fendler, Wolfgang Peter Herrmann, Ken Radtke, Jan Philipp Hadaschik, Boris Alexander Tschirdewahn, Stephan Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title | Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title_full | Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title_fullStr | Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title_full_unstemmed | Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title_short | Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
title_sort | prostate specific membrane antigen-radio guided surgery using cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls |
topic | Original Article on Management of Advanced Genitourinary Malignancies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575587/ https://www.ncbi.nlm.nih.gov/pubmed/34804840 http://dx.doi.org/10.21037/tau-20-1141 |
work_keys_str_mv | AT darrchristopher prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT fragosocostapedro prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT keschclaudia prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT krafftulrich prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT pullenlukas prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT harkeninanatascha prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT hessjochen prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT szarvastibor prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT hauboldjohannes prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT reishenning prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT fendlerwolfgangpeter prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT herrmannken prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT radtkejanphilipp prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT hadaschikborisalexander prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls AT tschirdewahnstephan prostatespecificmembraneantigenradioguidedsurgeryusingcerenkovluminescenceimagingutilizationofashortpassfiltertoreducetechnicalpitfalls |